Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,673 | -844 | -354 | -2,169 | 3,811 |
| Depreciation Amortization | 996 | 707 | 413 | 188 | 715 |
| Accounts receivable | 258 | -227 | -151 | 213 | 596 |
| Other Working Capital | 928 | -32 | -314 | 5 | -4,557 |
| Other Operating Activity | -3,318 | -3,399 | -2,912 | 671 | -8,449 |
| Operating Cash Flow | $-4,809 | $-3,796 | $-3,318 | $-1,091 | $-7,884 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -181 | -291 | -387 | -275 | -1,098 |
| Purchase Sale Intangibles | N/A | N/A | -75 | -61 | N/A |
| Other Investing Activity | -94 | -86 | -75 | -61 | -7 |
| Investing Cash Flow | $-275 | $-377 | $-462 | $-336 | $-1,105 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -220 |
| Common Stock Issued | 2,354 | 1,390 | 1,138 | 606 | 9,450 |
| Other Financing Activity | -682 | -567 | -395 | -200 | -1,158 |
| Financing Cash Flow | $1,671 | $824 | $742 | $405 | $8,071 |
| Beginning Cash Position | 10,984 | 10,984 | 10,984 | 10,984 | 11,512 |
| End Cash Position | 7,571 | 7,635 | 7,947 | 9,962 | 10,595 |
| Net Cash Flow | $-3,413 | $-3,349 | $-3,037 | $-1,022 | $-918 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,809 | -3,796 | -3,318 | -1,091 | -7,884 |
| Capital Expenditure | -181 | -291 | -387 | -275 | -1,098 |
| Free Cash Flow | -4,990 | -4,087 | -3,704 | -1,366 | -8,982 |